瓣环成形术系统市场 - 按刚性、按应用、按形状、按最终用途和预测，2024 年至 2032 年

由于外科心臟瓣膜修復和置换手术的普及，全球瓣环成形系统市场预计从 2024 年到 2032 年复合年增长率将超过 8.2%。根据疾病管制与预防中心的数据，瓣膜性心臟病影响着 2.5% 的人口和 13% 的 80 岁及以上老年人。这增加了对瓣环成形系统的巨大需求，以治疗这些疾病并改善患者的治疗效果。

随着医疗保健提供者优先考虑二尖瓣和三尖瓣疾病等心血管疾病的有效治疗，对可靠的瓣环成形术解决方案的需求不断增长。外科干预措施的激增凸显了旨在改善患者治疗效果和生活品质的先进医疗干预措施的更广泛趋势。随着全球越来越多的患者选择手术治疗，在有效解决和管理心臟健康的迫切需求的推动下，市场不断扩大。

整个瓣环成形系统市场根据刚性、应用、形状、最终用途和区域进行分类。

由于手术技术和材料的进步，从 2024 年到 2032 年，柔性细分市场的复合年增长率将大幅成长。这些系统在满足心臟瓣膜修復手术期间不同的解剖复杂性和患者特定需求方面提供了更大的灵活性和适应性。柔性瓣环成形环和带的创新使外科医生能够实现更精确的调整和更好的结果，从而最大限度地降低术后併发症的风险。这种灵活性趋势反映了向个人化医疗和微创方法的更广泛转变，刺激了有效适应不同患者状况的瓣环成形系统的采用。

到 2032 年，由于人们越来越认识到三尖瓣疾病及其对心臟健康的影响，三尖瓣修復领域将在瓣环成形术系统市场中占据显着份额。随着意识和诊断能力的提高，越来越多的患者被诊断出三尖瓣关闭不全，促使人们更加需要瓣环成形术等有效的治疗方案。这些系统在恢復瓣膜功能和改善患者预后方面发挥着至关重要的作用，特别是在需要手术干预的情况下。针对三尖瓣修復的瓣环成形技术的进步正在提高手术精度和术后恢復，从而扩大了其在临床实践中的应用。

2024年至2032年，亚太地区瓣环成形系统市场将呈现强劲的复合年增长率。心臟治疗的需求。此外，亚太地区人口老化导致心臟瓣膜疾病的发生率升高，因此需要进行包括瓣环成形术在内的外科手术介入。医疗保健设施的改善和微创手术技术的采用鼓励了亚太地区的市场扩张。这些因素共同凸显了增强心臟护理能力的日益增长的趋势。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 心血管疾病负担日益加重
    • 瓣环成形术系统的技术进步
    • 对微创手术的需求不断增长
  • 产业陷阱与挑战
    • 潜在的併发症和不良事件
• 成长潜力分析
• 监管环境
• 技术景观
• 未来市场趋势
• 报销场景
• 波特的分析
• PESTEL分析
• 缺口分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按刚性划分，2021 - 2032 年

• 主要趋势
• 灵活的
• 死板的
• 半刚性

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 二尖瓣修復
• 三尖瓣修復
• 主动脉瓣修补

第 7 章：市场估计与预测：按形状分类，2021 - 2032

• 主要趋势
• 打开
• 关闭

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 心导管实验室
• 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Abbott Laboratories
• Affluent Medical
• BioStable Science & Engineering
• Corcym UK Limited
• Coroneo
• Edwards Lifesciences Corporation
• Genesee BioMedical
• Medtentia International Ltd Oy
• Medtronic plc
• Micro Interventional Devices Incorporated

Global Annuloplasty System Market will imply over 8.2% CAGR from 2024 to 2032, driven by the prevalence of surgical heart valve repair and replacement procedures. As per the Centers for Disease Control and Prevention, valvular heart disease influences 2.5% of the population and 13% of those aged 80 years and above. This has strengthened significant demand for annuloplasty systems to treat these conditions and enhance patient outcomes.

As healthcare providers prioritize effective treatments for cardiovascular conditions such as mitral and tricuspid valve disorders, the need for reliable annuloplasty solutions has grown. This surge in surgical interventions underscores a broader trend towards advanced medical interventions aimed at improving patient outcomes and quality of life. With a rising number of patients opting for surgical treatments globally, the market continues to expand, driven by the imperative to address and manage cardiac health effectively.

The overall annuloplasty system market is categorized based on rigidity, application, shape, end-use, and region.

The flexible segment will experience considerable CAGR expansion from 2024 through 2032, owing to surgical techniques and materials advancements. These systems offer greater flexibility and adaptability in addressing varying anatomical complexities and patient-specific needs during heart valve repair procedures. Innovations in flexible annuloplasty rings and bands allow surgeons to achieve more precise adjustments and better outcomes, minimizing the risk of postoperative complications. This trend towards flexibility reflects a broader shift towards personalized medicine and minimally invasive approaches, spurring the adoption of annuloplasty systems that accommodate diverse patient conditions effectively.

By 2032, the tricuspid valve repair segment will achieve a prominent annuloplasty system market share because of a growing recognition of tricuspid valve disorders and their impact on cardiac health. As awareness and diagnostic capabilities improve, more patients are diagnosed with tricuspid valve regurgitation, prompting a greater need for effective treatment options like annuloplasty. These systems play a crucial role in restoring valve function and improving patient outcomes, especially in cases where surgical intervention is necessary. Advances in annuloplasty technologies tailored for tricuspid valve repair are enhancing surgical precision and postoperative recovery, escalating their adoption in clinical practice.

The Asia Pacific annuloplasty system market will exhibit a robust CAGR from 2024 to 2032. Rising healthcare expenditures and increasing awareness and diagnosis of cardiovascular diseases are thrusting demand for advanced cardiac treatments, including annuloplasty procedures. Additionally, the Asia Pacific's aging population is contributing to higher incidences of heart valve disorders, necessitating surgical interventions that include annuloplasty. Improved access to healthcare facilities and the adoption of minimally invasive surgical techniques encourages market expansion in the Asia Pacific. These factors collectively underscore a growing trend toward enhancing cardiac care capabilities.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing burden of cardiovascular diseases
    • 3.2.1.2 Technological advancements in annuloplasty systems
    • 3.2.1.3 Rising demand for minimally invasive procedures
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Potential complications and adverse events
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Reimbursement scenario
• 3.8 Porter's analysis
• 3.9 PESTEL analysis
• 3.10 GAP analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Rigidity, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Flexible
• 5.3 Rigid
• 5.4 Semi-rigid

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Mitral valve repair
• 6.3 Tricuspid valve repair
• 6.4 Aortic valve repair

Chapter 7 Market Estimates and Forecast, By Shape, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Open
• 7.3 Closed

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Cardiac catheterization labs
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Abbott Laboratories
• 10.2 Affluent Medical
• 10.3 BioStable Science & Engineering
• 10.4 Corcym UK Limited
• 10.5 Coroneo
• 10.6 Edwards Lifesciences Corporation
• 10.7 Genesee BioMedical
• 10.8 Medtentia International Ltd Oy
• 10.9 Medtronic plc
• 10.10 Micro Interventional Devices Incorporated